FDA grants priority review to Roche's leukemia drug

ZURICH (Reuters) - Swiss drugmaker Roche Holding AG said on Wednesday U.S. health regulators have granted priority review to its experimental leukemia treatment GA101.

via Reuters: Health News Read More Here..

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/07/fda-grants-priority-review-to-roche_3.html